Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag for ITP Secondary to Chronic Lymphoproliferative Disorders
NCT01610180Phase 2Completed
- Sponsor
- Fondazione Progetto Ematologia
- Start
- Jun 2012
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eltrombopag in immune thrombocytopenia (ITP), sponsored by Fondazione Progetto Ematologia. Started Jun 2012; status: completed.
02
Drugs
eltrombopag
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT01610180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01610180.